Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:05 PM
Ignite Modification Date:
2025-12-24 @ 5:05 PM
NCT ID:
NCT03380650
Eligibility Criteria:
Inclusion Criteria:
* age of 18-80 years old
* patients of femoropopliteal occlusive disease (Rutherford 2-4)
* length of lesion ≤ 20cm
* have signed the informed consent
Exclusion Criteria:
* serum Cr \> 150 umol/L
* patients with acute thrombosis
* received endovascular treatment for femoropopliteal disease in recent 6 months
* less than 1 run-off vessel
* allergic to aspirin, heparin, clopidogrel, paclitaxel, contrast medium
* pregnancy and lactation
* relatively easy bleeding
* malignancy or irreversible organ failure
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT03380650
Study Brief:
Protocol Section:
NCT03380650